HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ICMAD Broadens Advocacy Focus With Cosmetics Reform A Low Priority In Congress

This article was originally published in The Rose Sheet

Executive Summary

Legislation to update cosmetics regulations may not have legs in the 115th Congress, but the Independent Cosmetic Manufacturers and Distributors will have an active presence on Capitol Hill regardless. President and CEO Pam Busiek says the small-business trade group will continue working to educate lawmakers on regulatory reform issues while expanding its advocacy work to address tax and trade concerns.

You may also be interested in...

Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners

The Personal Care Products Safety Act introduced in the Senate May 11, and the Cosmetic Modernization Amendments Act that launched in the House earlier this year, closely mirror versions that divided big and small business in the last Congress. So while the US political environment may be dramatically changed, the legislative situation for stakeholders seeking updated cosmetics regulations, at the moment, is not.

Cosmetics Provisions Unlikely To Catch Ride On FDA User-Fee Bill

With the release of an atypically lean, clean FDA user-fee reauthorization draft bill, it’s doubtful that cosmetics regulatory reform language will get tacked onto the must-pass legislation. Stakeholders likely will refocus their efforts on standalone cosmetics legislation to modernize FDA’s oversight of the industry.

Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform

The Personal Care Products Council expects at least three cosmetics reform bills to make reappearances in the 115th Congress, but the best opportunity for updating regulations may involve tacking related provisions onto must-pass FDA user-fee bills this year. Top execs discussed the current legislative landscape during the “Washington Report” session of the trade group’s annual meeting in Palm Beach, Fla.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts